Inside Scope

Episode 2 of our new series Innovation in Duodenoscope Design is all about disposable scopes! Join host Adarsh Thaker, MD, and his guests Gregory A. Cote, MD, and Andrew Ross, MD, as they cover:

• How to determine whether a scope is clean or not and how to know it is ready for the next patient.

• Cost and reimbursement factors into declaring that the risk of exogenous is "low".

• If single use duodenoscopes make sense not only in infection prevention but also in the cost to the environment.

This series is supported by an unrestricted educational grant from Boston Scientific.

To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.

Welcome to our new series Innovation in Duodenoscope Design! Episode one is hosted by Adarsh Thaker, MD. He is joined by Shani Haugen, PhD, who will help us understand how the FDA is addressing duodenoscope-related infection issues. They’ll answer key questions like what do FDA’s Safety Communications mean for GIs, what have we learned from 522 studies, and what do we still have to learn?

This series is supported by an unrestricted educational grant from Boston Scientific.

To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion.

In episode 4 of 4, we're joined by guests Shuba Bhat, PharmD, and Miguel Regueiro, MD, to discuss:

• Their approach to shared decision-making with a patient that’s concerned about a switch. And how often does this occur?

• Do you suggest that the patient speak with multiple team members?

• As a clinical pharmacist how do you counsel these patients?

• What is the general approach to switching used at Cleveland Clinic and what do you find has been most helpful?

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion.

In episode 3 of 4, we're joined by guests Shuba Bhat, PharmD, and Jennifer Seminerio-Diehl, MD, to discuss:

• What are the practical logistics when you work on a switch with a patient?

• How do you address a situation where a patient says they are experiencing an increase in symptoms after a switch?

• Are there any situations where you would consider appealing an insurance decision and not switching?

• What tests do you use to determine whether a patient is experiencing active disease before or after a switch?

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.

In episode 2 of 4, we’ll discuss:

• How do you prepare your team and the patient for a switch to a biosimilar?

• Are there any situations where switching is not appropriate?

• What do you think about multiple switches?

• How do you minimize the potential for a nocebo effect?

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.

In episode 1 of 4, we’ll discuss:

• How do you explain biosimilars to a patient with moderate-to-severe Crohn’s disease when you start them on a biologic?

• What are some of the common questions that patients ask and how do you address them?

• Do you set goals of therapy with your patients and what are they?

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.

This is episode 4 of our 5-part series Colorectal Cancer: Screening to Save Lives. We talk about important considerations when caring for individuals at high risk for poor outcomes in colorectal cancer due to social determinants of health.

In this episode:

• David Lieberman, MD, professor of medicine in the division of Gastroenterology and Hepatology at the Oregon Health & Science University

• Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center

This season is supported by an independent medical education grant from Exact Sciences.

In our final episode of our 5-part series Colorectal Cancer: Screening to Save Lives, we share updated information about coverage, cost-sharing, reimbursement and coding for colorectal cancer screening.

In this episode:

• David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University

• Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center

• Shivan Mehta, MD, assistant professor of medicine and health policy at Perelman School of Medicine and associate chief innovation officer at Penn Medicine Center for Innovation

This season is supported by an independent medical education grant from Exact Sciences.

This is episode 3 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about the importance of primary care providers in identifying and managing patients at high risk for colorectal cancer.

In this episode:

• David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University

• Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center

• Swati Patel, MD, associate professor and director of the Gastrointestinal Cancer Risk and Prevention Center at the University of Colorado School of Medicine Anschutz Medical Campus.

This season is supported by an independent medical education grant from Exact Sciences.

This is episode 2 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about strategies for promoting initiation of colorectal cancer screening at age 45 and addressing early-onset colorectal cancer.

In this episode:

• David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University

• Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center

• Samir Gupta, MD, associate professor of clinical medicine at the University of California San Diego and the San Diego Veterans Affairs Healthcare System

This season is supported by an independent medical education grant from Exact Sciences.